Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:

NCT ID: NCT00123019 Completed - Obesity Clinical Trials

Work, Weight, and Wellness Program: The 3W Program

Start date: September 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to increase physical activity, improve diet, and reduce obesity of hotel employees.

NCT ID: NCT00123006 Completed - Hypertension Clinical Trials

Effectiveness of the DASH Diet at Reducing High Blood Pressure

Start date: January 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effects of the DASH diet in patients with isolated systolic hypertension.

NCT ID: NCT00122993 Completed - Obesity Clinical Trials

Worksite Program to Prevent Weight Gain Among Bus Drivers

Start date: September 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to implement and evaluate a two-year multi-component environmental intervention to prevent weight gain among city bus drivers at four bus garages. It is hypothesized that transit employees in the intervention garages will gain less weight compared to the transit employees in the control garages.

NCT ID: NCT00122928 Completed - Obesity Clinical Trials

Comparison of Workplace Obesity Management Programs

Start date: October 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to design and demonstrate the feasibility of implementing moderate and intensive environmental obesity prevention programs at major worksites.

NCT ID: NCT00122447 Completed - Clinical trials for Impaired Glucose Tolerance

Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance

Start date: May 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether cardiovascular disease (CVD) risk markers, β-cell function, and insulin sensitivity can be improved by targeting mechanisms of both diabetes and CVD - using an antioxidant, an angiotensin II receptor blocker (ARB), or an anti-inflammatory agent - in patients with impaired glucose tolerance (IGT) in a randomized, controlled trial.

NCT ID: NCT00121550 Completed - Clinical trials for Cardiovascular Disease

The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease

Start date: October 1999
Phase: Phase 3
Study type: Interventional

A growing body of evidence links Chlamydia pneumoniae to the progression of coronary heart disease. The purpose of this study is to determine the positive and negative effect of 14 days treatment with clarithromycin 500 mg daily in patients already suffering from stable coronary heart disease. The participants will be followed for at least two years after the treatment. Abbott Laboratories supplied Clarithromycin and placebo tablets.

NCT ID: NCT00120991 Active, not recruiting - Clinical trials for Cardiovascular Disease

Best Bypass Surgery (BBS) Trial

Start date: April 2002
Phase: Phase 3
Study type: Interventional

There is evidence linking cardiopulmonary bypass to negative side effects when used for coronary artery bypass grafting. Coronary artery bypass grafting can be performed without the use of cardiopulmonary bypass. The purpose of this study is to determine the positive and negative effects of coronary artery bypass grafting with or without the use of cardiopulmonary bypass. The patients will be followed at least one year after surgery.

NCT ID: NCT00120289 Terminated - Clinical trials for Cardiovascular Diseases

Niacin Plus Statin to Prevent Vascular Events

Start date: September 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether raising "good cholesterol" with a drug based on the vitamin niacin, while lowering "bad cholesterol" with a statin drug, can prevent more heart disease than the statin alone.

NCT ID: NCT00120107 Completed - Clinical trials for Cardiovascular Disease

Tea's Effect on Atherosclerosis Pilot Study (TEA Study)

Start date: July 2003
Phase: N/A
Study type: Interventional

The researchers propose a pilot study of the effect of long-term tea intake on atherosclerosis. Thirty patients at high risk for cardiovascular disease will be recruited and randomized to a six-month period of consumption of 3 cups per day of either tea, supplied as black tea solids readily dissolved in hot or cold liquid, or water. At baseline and after 6 months, atherosclerosis in the aorta will be assessed using magnetic resonance imaging. The primary outcomes of this pilot study will be compliance with tea intake and 2 MRI examinations. As secondary outcomes, standard and novel cardiovascular risk markers, including inflammatory, prothrombotic, fibrinolytic, vascular and metabolic factors will be measured. If successful, this pilot study will form the basis for a larger, long-term randomized trial to determine the effect of tea consumption on progression of atherosclerosis.

NCT ID: NCT00119847 Completed - Clinical trials for Cardiovascular Diseases

Electrophysiological Effects of Late PCI After MI

Start date: September 2002
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if opening blocked arteries with heart balloons and stents prevents heart rhythm problems in individuals 3 to 28 days after a heart attack.